Passive Immunotherapy for HIV & AIDS Patents

Passive Immunotherapy for HIV & AIDS Patents
Passive Immunotherapy is a process in which individuals with advanced disease (who have low levels of HIV antibody production) are infused with plasma rich in HIV antibodies or an immunoglobulin concentrate (HIVIG) from such plasma. The plasma is obtained from asymptomatic HIV-positive individuals with high levels of HIV antibodies.

Passive immunotherapy is called passive because it involves giving someone else's antibodies to the recipients, as opposed to therapies like vaccines which encourage the body to make its own antibodies.

Passive immunotherapy is an unlicensed, experimental therapy.

Side-effects of the treatment can include headaches, nausea, fevers, coldness in the hands and feet and transient rashes.

The benefits of passive immunotherapy in treating HIV patents are still unclear and so the treatment is still in experimental stages.